|
RFXAP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.079600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.986200E-01 |
| Normal-vs-Stage2 |
6.498600E-01 |
| Normal-vs-Stage3 |
5.426300E-04 |
| Normal-vs-Stage4 |
3.631300E-04 |
| Stage1-vs-Stage2 |
8.962400E-01 |
| Stage1-vs-Stage3 |
6.022700E-04 |
| Stage1-vs-Stage4 |
3.792900E-04 |
| Stage2-vs-Stage3 |
1.197560E-01 |
| Stage2-vs-Stage4 |
7.150500E-02 |
| Stage3-vs-Stage4 |
6.166200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.698180E-02 |
| Normal-vs-AfricanAmerican |
1.939560E-01 |
| Normal-vs-Asian |
7.662400E-01 |
| Caucasian-vs-AfricanAmerican |
7.923200E-01 |
| Caucasian-vs-Asian |
3.993800E-01 |
| AfricanAmerican-vs-Asian |
4.226200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.644700E-03 |
| Normal-vs-Female |
4.608600E-01 |
| Male-vs-Female |
1.370110E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.851900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.348390E-01 |
| Normal-vs-Age(61-80Yrs) |
1.524120E-02 |
| Normal-vs-Age(81-100Yrs) |
1.225170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.315600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.493600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.702600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.810600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.430800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.758800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.031700E-02 |
| Normal-vs-Grade 2 |
7.079800E-01 |
| Normal-vs-Grade 3 |
9.68350000000173E-05 |
| Normal-vs-Grade 4 |
1.72674999999733E-05 |
| Grade 1-vs-Grade 2 |
1.466370E-01 |
| Grade 1-vs-Grade 3 |
2.205400E-04 |
| Grade 1-vs-Grade 4 |
7.197900E-04 |
| Grade 2-vs-Grade 3 |
1.84199999997414E-06 |
| Grade 2-vs-Grade 4 |
3.03769999998593E-06 |
| Grade 3-vs-Grade 4 |
4.429700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.488200E-01 |
| Normal-vs-ccB subtype |
4.14709999996266E-06 |
| ccA subtype-vs-ccB subtype |
8.81949957509676E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.462100E-02 |
| Normal-vs-N1 |
2.005600E-04 |
| N0-vs-N1 |
7.016400E-03 |
|
|
